API Security in a Fragmented World: Navigating the New Global Supply Chain Reality

Pharmaceutical supply chains are entering a new era of geopolitical fragmentation. Governments across the US, Europe, and Asia are introducing policies designed to secure access to critical medicines and reduce vulnerabilities in pharmaceutical supply.

Initiatives such as the European Critical Medicines Act in Europe and reshoring efforts in the United States are accelerating pressure on companies to rethink long-established sourcing strategies. Yet translating these ambitions into operational supply chain change remains highly complex.

This panel explores how pharmaceutical companies are responding to this evolving policy landscape. From mapping hidden API dependencies to qualifying alternative suppliers and balancing resilience with cost pressures, industry leaders will discuss what it takes to build more secure pharmaceutical supply networks in practice.